Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Single-center, Uncontrolled, Retrospective, the Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum

NCT02847065 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT02847065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02847065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Single-center, Uncontrolled, Retrospective, the Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Completed
Start date
November 3, 2015
Completion date
April 30, 2016
Enrollment
144 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

beta-lactamase extended spectrum, e. coli, elderly, mortality, risk factor